Pfizer temporarily closes India cancer drug plant, adding to shortages

· Health · India · United States

Pfizer has been forced to temporarily close a cancer drug factory in India, a site that will not reopen for up to two years and is already contributing to cancer drug shortages. The closure follows heavy monsoon rain in July, according to the report. The disruption matters because the plant supplies oncology medicines whose absence can delay treatment for patients who have few alternatives. Pfizer, one of the largest global drugmakers, now faces the challenge of reallocating supply from other sites while it repairs the Indian facility. The episode also highlights how concentrated manufacturing of cancer drugs can leave global supply chains exposed to local weather and infrastructure shocks.

Why it matters：A multi-year outage at a single oncology plant shows how concentrated drug manufacturing can translate a local weather event into global cancer drug shortages.

Key points

  • The factory will not reopen for up to two years.
  • The closure is already contributing to cancer drug shortages.
  • Heavy monsoon rain in July triggered the shutdown.

Sources (original reporting)

More stories from this day